{"id":4611,"date":"2023-09-06T12:06:07","date_gmt":"2023-09-06T12:06:07","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/alport-connect-2023-the-annual-alport-syndrome-patient-and-family-meeting-in-us\/"},"modified":"2024-04-26T12:23:43","modified_gmt":"2024-04-26T12:23:43","slug":"alport-connect-2023-the-annual-alport-syndrome-patient-and-family-meeting-in-us","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/alport-connect-2023-the-annual-alport-syndrome-patient-and-family-meeting-in-us\/","title":{"rendered":"Alport Connect 2023, la rencontre annuelle am\u00e9ricaine avec les patients atteints du syndrome d&#8217;Alport"},"content":{"rendered":"<p>7-8 Octobre, 2023<br \/>\nSan Diego, CA<\/p>\n<p>Â鶹Æƽâ°æ soutient la fondation am\u00e9ricaine pour les patients atteints du syndrome d&#8217;Alport (Alport Syndrome Foundation, ASF) et participera \u00e0 l&#8217;\u00e9v\u00e8nement annuel Alport Connect 2023, organis\u00e9 les 7 et 8 octobre \u00e0 San Diego, pour rencontrer les patients et leur famille mais aussi leur pr\u00e9senter la prochaine \u00e9tude clinique de Phase 2 avec Vonafexor chez les patients atteints du syndrome d&#8217;Alport.<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"CoVdp6JPZ6\"><p><a href=\"https:\/\/alportsyndrome.org\/for-patients\/alport-connect\/\">Alport Connect Meetings<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Alport Connect Meetings&#8221; &#8212; Alport Syndrome Foundation\" src=\"https:\/\/alportsyndrome.org\/for-patients\/alport-connect\/embed\/#?secret=uf4aH2tgbe#?secret=CoVdp6JPZ6\" data-secret=\"CoVdp6JPZ6\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>7-8 Octobre, 2023<br \/>\nSan Diego, CA<\/p>\n<p>Â鶹Æƽâ°æ soutient la fondation am\u00e9ricaine pour les patients atteints du syndrome d&#8217;Alport (Alport Syndrome Foundation, ASF) et participera \u00e0 l&#8217;\u00e9v\u00e8nement annuel Alport Connect 2023, organis\u00e9 les 7 et 8 octobre \u00e0 San Diego, pour rencontrer les patients et leur famille mais aussi leur pr\u00e9senter la prochaine \u00e9tude clinique de Phase 2 avec Vonafexor chez les patients atteints du syndrome d&#8217;Alport.<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"CoVdp6JPZ6\">\n<p><a href=\"https:\/\/alportsyndrome.org\/for-patients\/alport-connect\/\">Alport Connect Meetings<\/a><\/p>\n<\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Alport Connect Meetings&#8221; &#8212; Alport Syndrome Foundation\" src=\"https:\/\/alportsyndrome.org\/for-patients\/alport-connect\/embed\/#?secret=uf4aH2tgbe#?secret=CoVdp6JPZ6\" data-secret=\"CoVdp6JPZ6\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/alport-connect-2023-the-annual-alport-syndrome-patient-and-family-meeting-in-us\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-4611","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/events-fr\/\" rel=\"category tag\">\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"7-8 Octobre, 2023 San Diego, CA Â鶹Æƽâ°æ soutient la fondation am\u00e9ricaine pour les patients atteints du syndrome d&#8217;Alport (Alport Syndrome Foundation, ASF) et participera \u00e0 l&#8217;\u00e9v\u00e8nement annuel Alport Connect 2023, organis\u00e9 les 7 et 8 octobre \u00e0 San Diego, pour rencontrer les patients et leur famille mais aussi leur pr\u00e9senter la prochaine \u00e9tude clinique&hellip;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=4611"}],"version-history":[{"count":4,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4611\/revisions"}],"predecessor-version":[{"id":4616,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4611\/revisions\/4616"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=4611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=4611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=4611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}